Performance-Based Agreements in Italy: ‘Trendy Outcomes’ or Mere Illusions? Livio GarattiniAlessandro Curto Commentary 03 June 2016 Pages: 967 - 969
Sustainable Financing of Innovative Therapies: A Review of Approaches Aidan Hollis Review Article 01 June 2016 Pages: 971 - 980
Daclatasvir for the Treatment of Chronic Hepatitis C: A Critique of the Clinical and Economic Evidence Alexis LlewellynRita FariaSusan Griffin Review Article 08 June 2016 Pages: 981 - 992
EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes Mark OppeKim Rand-HendriksenNan Luo Practical Application Open access 15 April 2016 Pages: 993 - 1004
The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in Japan Haruhisa FukudaShunya IkedaTakashi Fukuda Original Research Article 25 March 2016 Pages: 1005 - 1014
Using Linear Equating to Map PROMIS® Global Health Items and the PROMIS-29 V2.0 Profile Measure to the Health Utilities Index Mark 3 Ron D. HaysDennis A. RevickiDavid Cella Original Research Article 26 April 2016 Pages: 1015 - 1022
A Model-Based Economic Evaluation of Biologic and Non-Biologic Options for the Treatment of Adults with Moderately-to-Severely Active Ulcerative Colitis after the Failure of Conventional Therapy Paul TappendenShijie RenSami Hoque Original Research Article 28 April 2016 Pages: 1023 - 1038
Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer Bonny ParkinsonRosalie VineySallie-Anne Pearson Original Research Article 20 May 2016 Pages: 1039 - 1050
BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles William C. N. DunlopC. Daniel MullinsLouise Heron Original Research Article Open access 04 July 2016 Pages: 1051 - 1065
Publication of Cost-of-Illness Studies: Does Methodological Complexity Matter? T. Joseph Mattingly IIC. Daniel MullinsEberechukwu Onukwugha Research Letter 08 August 2016 Pages: 1067 - 1070